Remove 2012 Remove Prescription Remove Side effects
article thumbnail

Improving Patient Portal Engagement with Pharma Content

PM360

Typically, results or new treatment prescriptions are simply uploaded to the portal with the doctors expected to give explanations during the appointment—even though the ability to provide additional information within the portal is readily available.

Pharma 105
article thumbnail

Innovating allergy drug delivery with a needle-free alternative

European Pharmaceutical Review

Additionally, EURneffy could alleviate the risk of accidental needle-related side effects (such as injection into the blood vessel and hand) 3 and it has the attributes of being smaller in size, has better temperature sensitivity, and is less complex to use compared to needle-based injectors. Hand (N Y). 2007; 2(1):5-11.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Quality of life in patients with chronic health conditions

World of DTC Marketing

According to the CDC, in 2012, 25.5% What happens when someone loses the will to live because they are tired of dealing with chronic health conditions and prescription drugs that have nasty side effects? of US adults had multiple (?2) Our healthcare system is designed to treat health conditions, not patients.

Patients 199
article thumbnail

The Role of Certified Pharmaceutical Representatives in the Shifting Sales Landscape

Pharmaceutical Representative Training

Preventing Misuse: Strict regulations are required to stop the improper use and abuse of drugs, especially those that have strong side effects or the potential to become addictive. In an effort to reduce the hazards connected with their use, regulations seek to regulate the prescription and distribution of these drugs.

Sales 52
article thumbnail

Beating the Big C

Pharmaceutical Technology

Between 2003 and 2005 global sales for cancer-treating drugs grew by 40% According to IMS Health, who tracks prescription drug sales, the global market for cancer drugs is still growing rapidly with around $48bn spent on oncology products in 2008; a figure which accounts for 17% of worldwide pharmaceutical sales.